Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta-1a in Iran (vol 127, pg 501, 2017)

Pakdaman Hossein; Harandi Ali Amini; Gharagozli Koroush; Abbasi Mehdi; Ashrafi Farzad; Kasmae Hosein Delavar; Assarzadegan Farhad; Behnam Mehran Arabahmadi Behdad

首页> 外文期刊>International Journal of Neuroscience >Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta-1a in Iran (vol 127, pg 501, 2017)

【24h】

Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta-1a in Iran (vol 127, pg 501, 2017)

机译：在伊朗皮下干扰素β-1A治疗的复发延迟多发性硬化症患者的健康状生活质量（Vol 127，PG 501,2017）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Neuroscience》 |2017年第6期|共1页
作者
Pakdaman Hossein; Harandi Ali Amini; Gharagozli Koroush; Abbasi Mehdi; Ashrafi Farzad; Kasmae Hosein Delavar; Assarzadegan Farhad; Behnam Mehran Arabahmadi Behdad;
展开▼
作者单位

Shahid Beheshti Univ Med Sci Brain Mapping Res Ctr Tehran Iran;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词

相似文献

外文文献
中文文献
专利

1. Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta-1a in Iran (vol 127, pg 501, 2017) [J] . Pakdaman Hossein, Harandi Ali Amini, Gharagozli Koroush, International Journal of Neuroscience . 2017,第1a6期

机译：在伊朗皮下干扰素β-1A治疗的复发延迟多发性硬化症患者的健康状生活质量（Vol 127，PG 501,2017）
2. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. [J] . Gasperini C Multiple sclerosis: clinical and laboratory research . 2011,第8期

机译：患有皮下注射干扰素β-1a的复发缓解型多发性硬化症的轻度残疾患者的生活质量，抑郁和疲劳：COGIMUS（多发性硬化症的认知功能减退）研究的3年结果。
3. Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis [J] . Arroyo Gonzalez Rafael, Kita Mariko, Crayton Heidi, Multiple sclerosis: clinical and laboratory research . 2017,第10期

机译：与患有活性复发的多发性硬化症的患者皮下干扰素Beta-1a相比，Alemtuzumab改善了生活质量结果
4. Managing the Quality of Life in Patients with Multiple Sclerosis: A Literature Review [C] . Antonios KEFALIAKOS, Ioannis PLIAKOS, Marianna DIOMIDOUS International Conference on Informatics, Management, and Technology in Healthcare . 2016

机译：患有多发性硬化症患者的生活质量：文献综述
5. Cost-Effectiveness of Oral Agents in Relapsing-Remitting Multiple Sclerosis Compared to Interferon-Based Therapy in Saudi Arabia [D] . Alskaabi, May. 2017

机译：沙特阿拉伯口服药物在复发缓解型多发性硬化症中的成本效果与基于干扰素的疗法相比
6. Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple Sclerosis [O] . Martina Novotna, Ales Tvaroh, Jan Mares 2020

机译：预测治疗后未来临床疾病活性的临床参数从患有延迟多发性硬化症的患者中的其他平台注射剂转变为高剂量皮下干扰素β-1a
7. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study [O] . Patti, F, Amato, M, Trojano, M, 2011

机译：患有皮下注射干扰素β-1a的复发缓解型多发性硬化症的轻度残疾患者的生活质量，抑郁和疲劳：COGIMUS（多发性硬化症认知功能障碍）研究的3年结果

Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta-1a in Iran (vol 127, pg 501, 2017)

著录项

相似文献

相关主题

期刊订阅